Advertisement
Home »

Management of Adverse Reactions Related to Lenvatinib Plus Pembrolizumab Treatment Among Patients With Renal Cell Carcinoma.

Jan 15, 2024

ABOUT THE EXPERTS

  • Viktor Grünwald

    Interdisciplinary Genitourinary Oncology, Clinic for Urology, Clinic for Medical Oncology, University Hospital Essen, Hufelandstraße 55, 45147 Essen, Germany. Electronic address: Viktor.Gruenwald@uk-essen.de.

    James Larkin

    The Royal Marsden Hospital, 203 Fulham Rd, SW3 6JJ, London, United Kingdom.

    Javier Puente

    Department of Medical Oncology, Hospital Clinico Universitario San Carlos, Calle del Prof Martín Lagos, S/N, 28040, Madrid, Spain.

    Jens Bedke

    Department of Urology & Transplantation Surgery, Klinikum Stuttgart Kriegsbergstraße., 60 70174 Stuttgart Germany.

    Camillo Porta

    Interdisciplinary Department of Medicine, University of Bari ‘A Moro’, Piazza Giulio Cesare 11 70124, Bari, Italy.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement